Trial Profile
A 6 Week Open Label, Dose Comparison Study to Evaluate the Safety and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Subjects With Hypercholesterolemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Mar 2006
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Atorvastatin; Pravastatin; Simvastatin
- Indications Hypercholesterolaemia; Hypertriglyceridaemia; Metabolic syndrome
- Focus Therapeutic Use
- Acronyms STELLAR
- Sponsors AstraZeneca
- 27 Mar 2006 New trial record.